Extension of Time to File SOU

FULIVIO

JOHNSON & JOHNSON

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88079656
LAW OFFICE ASSIGNED LAW OFFICE 109
MARK SECTION
MARK FULIVIO (see, http://uspto.report/TM/88079656/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT FULIVIO
OWNER SECTION (current)
NAME JOHNSON & JOHNSON
MAILING ADDRESS One Johnson & Johnson Plaza
CITY New Brunswick
STATE New Jersey
ZIP/POSTAL CODE 08933
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
OWNER SECTION (proposed)
NAME JOHNSON & JOHNSON
MAILING ADDRESS One Johnson & Johnson Plaza
CITY New Brunswick
STATE New Jersey
ZIP/POSTAL CODE 08933
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME MATTHEW PATER
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmus@its.jnj.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kmanchen@its.jnj.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 03/12/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /mapjnj/
SIGNATORY'S NAME Matthew Pater
SIGNATORY'S POSITION Attorney of Record
DATE SIGNED 02/21/2020
SIGNATORY'S PHONE NUMBER 732-524-2826
FILING INFORMATION
SUBMIT DATE Fri Feb 21 15:13:01 ET 2020
TEAS STAMP USPTO/ESU-XXX.XX.X.XX-202
00221151301951298-8807965
6-7107ad8b58cfac95891ec47
ea5a4e26a91328f1415b2b342
27a4c59b069a5723c6b-DA-13
011454-202002211139548447
28



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: FULIVIO (see, http://uspto.report/TM/88079656/mark.png)
SERIAL NUMBER: 88079656

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: JOHNSON & JOHNSON, having an address of
      One Johnson & Johnson Plaza
      New Brunswick, New Jersey 08933
      United States
Proposed: JOHNSON & JOHNSON, having an address of
      One Johnson & Johnson Plaza
      New Brunswick, New Jersey 08933
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 03/12/2019.

For International Class 005:
Current identification: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /mapjnj/      Date Signed: 02/21/2020
Signatory's Name: Matthew Pater
Signatory's Position: Attorney of Record
Signatory's Phone: 732-524-2826

RAM Sale Number: 88079656
RAM Accounting Date: 02/21/2020

Serial Number: 88079656
Internet Transmission Date: Fri Feb 21 15:13:01 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XX.X.XX-202002211513019512
98-88079656-7107ad8b58cfac95891ec47ea5a4
e26a91328f1415b2b34227a4c59b069a5723c6b-
DA-13011454-20200221113954844728



Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed